Contact
Please use this form to send email to PR contact of this press release:
Genmab Announces Ofatumumab Phase III Study in Follicular Lymphoma to be Stopped Following Planned Interim Analysis
TO:
Please use this form to send email to PR contact of this press release:
Genmab Announces Ofatumumab Phase III Study in Follicular Lymphoma to be Stopped Following Planned Interim Analysis
TO: